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1. Introduction  9 
When a particle or microorganism enters the host, is readily phagocytosed by the local 10 
macrophages and dendritic cells. If the microorganism is a non-pathogenic bacteria such as 11 
Mycobacterium smegmatis, the bacteria containing phagosomes will fully mature. Maturation 12 
refers to a multi-dimensional and complex process that integrates biochemical alterations on 13 
the phagosomal membranes, resulting as a direct response from the external stimuli and 14 
indirectly from the immediate response at the gene expression level in the form of 15 
transcriptional programs, as well as from its regulation. This, in turn, leads to modifications 16 
at the intracellular architecture, with the reorganization of the organelle dynamics, 17 
dependent on the assembly of actin, and resulting ultimately in the fusion of phagosomes 18 
with lysosomes. Not only several biochemical pathways have been implicated, but also 19 
physical and mechanical events will determine the faith of the bacteria containing 20 
phagosome. At the biochemical level, acidic hydrolases and the proton ATPase will reach 21 
the phagosomes while maturing and promote the lowering of the intraphagosomal pH, 22 
thereafter contributing to the killing of the bacteria. The production of nitric oxide (NO) by 23 
the inducible nitric oxide synthase (iNOS) and the reactive oxygen species (ROS) by 24 
phagosome oxidases (phox) is also known to be important for the bacterial killing. NO and 25 
cytokines are an important part of the inflammatory response which is downstream of 26 
transcription factors such as nuclear factor-!B (NF- !B). 27 
When the pathogenic Mycobacterium tuberculosis enters the macrophage phagosome, the 28 
maturation process is blocked. We have shown that at least three distinct processes are 29 
targeted: actin assembly, fusion with lysosomes and acidification (Anes et al., 2003, Anes et 30 
al., 2006, Castandet et al., 2005). It has been suggested that specific M. tuberculosis lipids such 31 
as the sulfolipids (Goren et al., 1976), and phenolic glicolipids (Rhoades et al., 2003), and 32 
secreted peptides (Walburger et al., 2004) have been implicated as effectors involved in 33 
blocking the phagosome maturation to phagolysosome. These factors, which have been 34 
reported to be transferred to different host membranes in infected cells, are likely to be the 35 
cause of the well-described inhibition of pro-inflammatory responses, including the 36 
inhibition of TNF- " secretion, and the restriction of phagosome motility. 37 
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These blocking mechanisms, which are still yet poorly understood, can somehow, be 1 
reversed. Our published data show that phagosome maturation is directly linked to actin 2 
assembly on membranes (Defacque et al., 2000). This will consequently lead the organelles 3 
to aggregate before they fuse with lysosomes (Jahraus et al., 2001). We also described the 4 
addition of several pro-inflammatory lipids to M. tuberculosis infected cells with surprisingly 5 
strong killing effects (Anes et al., 2003, Gutierrez et al., 2009, Jordao et al., 2008). These 6 
selected lipids can manipulate the phagolysosome maturation by interfering with the actin 7 
machinery. In addition to these signaling lipids, ATP, the P2X7 receptor and cAMP were 8 
shown to be involved in actin assembly and the killing/survival of pathogenic mycobacteria 9 
(Kalamidas et al., 2006, Kuehnel et al., 2009, Kuehnel et al., 2009b). Furthermore, some lipid 10 
effectors for actin assembly also control NF-kB (Gutierrez et al., 2009). Using microarray 11 
analysis, we linked NF-kB in the regulation of many lysosomal enzymes and membrane-12 
trafficking regulators, including cathepsins, LAMP-2 and Rab34, during infection (Gutierrez 13 
et al., 2008). 14 
Important classes of lipids that are effectors for actin assembly and for NF-kB control 15 
include eicosanoids. Eicosanoides produced from arachidonic acid such lipoxin X4 (LX4) as 16 
well ATP, and the P2X7 R are all additionally involved in a necrotic-programmed cell death 17 
(Chen et al., 2008). Distinct molecules were found to play opposite roles either inducing 18 
apoptosis or necrosis during infection. In fact while virulent M. tuberculosis promotes 19 
necrotic cell death and inhibits apoptosis, the non-virulent strain H37Ra induces apoptosis 20 
that results in lower bacterial viability. Pyroptosis in the context of tuberculosis is 21 
controversial: from one side it leads to potent pro-inflammation that drives tuberculosis; 22 
from other side it allows the release of intracellular bacteria and their escape to hydrolytic 23 
digestion. This type of programmed cell death depends on the assembly of a specific 24 
inflammasome leading to caspase 1 activation and IL-1# and IL-18 secretion. Some groups 25 
claimed that M. tuberculosis might block the inflammasome activation (Master et al., 2008). 26 
We have shown that M. tuberculosis in human macrophages, not only activates caspase 1 and 27 
IL1-# secretion but also that different inflammasomes are assembled during infection 28 
(Mishra et al., 2010). 29 
So we propose in this chapter to present an overview of host factors that may be 30 
manipulated in order to reverse phagosome maturation arrest, NF-kB translocation, 31 
inflammasome activation and therefore boosting the macrophage killing abilities to Koch’s 32 
bacilli. 33 
2. The disease 34 
Tuberculosis is usually a lung infection caused by inhalation of Koch’s bacilli within 35 
microdroplets, but it can affect any organ. In the lung, bacilli are envisaged to be engulfed 36 
by cell patrolling the alveolar surface such as alveolar macrophages and tissue dendritic 37 
cells (DC). These cells transport the pathogens to the lung interstitium and draining lymph 38 
nodes. At both sites, primary lesions develop that rarely cause disease. These professional 39 
phagocytes that are devoted to maintain the lungs cleaned from particles, produce a series 40 
of bacterial insults designed to kill pathogens. However M. tuberculosis developed capacities 41 
to subvert the killing mechanisms of phagocytes to allow their intracellular survival and/or 42 
replication. The first contact with these phagocytic cells will display a series of innate 43 
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immune mechanisms that may lead to the complete clearance of the bacilli. These include 1 
the release of NO, ROS, the fusion of the phagosome with the lysosome with the 2 
simultaneously bacteria digestion by acidic hydrolases and antimicrobial peptides (Cooper 3 
et al., 2000, Liu et al., 2007, MacMicking et al., 1997). Ultimately the programmed cell death 4 
of the infected host cell will kill the reminiscent infecting bacteria (Park et al., 2006).  5 
Furthermore the initially infected cells release pro-inflammatory cytokines which leads to 6 
recruitment of more DC, monocytes and neutrophils from the blood stream and the infected 7 
DC become mature and migrate to the local lymph node where they activate specific T cells. 8 
The cytokines IL-12 and IL-18 from the infected cells induce natural killer cell (NK) activity, 9 
and the NK cells in turn produce IFN-!, which activates the macrophages to produce TNF-" 10 
and more microbicidal effectors (Korbel et al., 2008). In fact resting phagocytic cells are 11 
designed to uptake and clear bacteria by phagolysosome fusion with full bacteria digestion, 12 
while activated macrophages are reprogrammed to produce more free radicals, and 13 
decrease the extend of bacteria digestion in order to produce antigens for immune cross 14 
presentation. Through cytokine and chemokine signaling, other immune cells are recruited 15 
and the pathological hallmark of TB, the granuloma, is formed. In the granuloma, 16 
macrophages differentiate further into epitheloid cells or foamy macrophages, or fuse to 17 
form giant cells, and become surrounded by lymphocytes and an outer cuff of fibroblasts 18 
and extracellular matrix proteins. At this stage infected people may complaint for symptoms 19 
that may resemble a simple cold. 20 
Thereby, the bacilli are contained until the granuloma fails due to immunosuppression 21 
(Russell, 2007). For a long time, the granuloma was viewed as beneficial only for the host – it 22 
coincided with the onset of adaptive immunity and reduction of bacterial growth in the lung 23 
– but recent studies in zebrafish embryos infected with a close relative of M. tuberculosis, 24 
Mycobacterium marinum, have indicated that mycobacteria also use the granuloma for their 25 
benefit upon initial infection, recruiting new macrophages to allow spread between host 26 
cells (Davis & Ramakrishnan, 2009). This stage were the centre of the granuloma is formed 27 
by infected macrophages usually is referred as a latent infection without disease symptoms 28 
and according to the World Health Organization (WHO reports 2008) corresponds to one 29 
third of the world infected people. From these only 5-10% will develop disease during their 30 
lifetime (Kaufmann & Parida, 2007). 31 
When the granuloma centre becomes caseous containing necrotic macrophages following 32 
necrotic programme cell death, latent infection becomes in active disease, which in 33 
advanced TB form cavities in the lung. Historical texts identify the disease as 34 
“consumption,” “wasting away,” “king’s evil,” “lupus vulgaris,” “the white plague” or 35 
“phthisis” based on its clinical manifestations (Donoghue, 2009). Although mycobacteria are 36 
able to survive and proliferate within phagocytes, it should be noted that during active 37 
pulmonary tuberculosis they are preferentially found in the extracellular space. The necrotic 38 
centers of infection sites during active disease contain liquefied, so-called caseating, debris. 39 
These lesions are rich in cellular detritus, membrane phospholipids and cholesterol, which 40 
serve as an important carbon source for mycobacteria. Spillage of infectious bacilli into the 41 
airways occurs when the structure ruptures, and this allows spread to new individuals 42 
(Russell, 2007).  43 
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The present overview of host innate immune response to M. tuberculosis highlight the 1 
relevance of the phagolysosome fusion, host programmed cell death and inflammation as 2 
important mechanisms whose possibility of control by molecular effectors may provide 3 
alternative therapies for TB. 4 
3. Phagosome maturation blockade into phagolysosome by M. tuberculosis: 5 
targeting phagosomal actin assembly, fusion and acidification 6 
Phagocytosis — the engulfment of particles by unicellular organisms and higher eukaryotic 7 
cells — was first observed and documented by Metchnikoff around the beginning of the last 8 
century. His observations with macrophages (“big eater” in Greek) persuaded him that 9 
these professional phagocytes were the primary defence against microbial invaders. 10 
Although this view garnered little support at the time, the central role of phagocytes in 11 
immune protection is now universally accepted. The successful completion of these 12 
protective activities requires maturation of the phagosome into an acidic, hydrolytically 13 
competent, organelle that can fuse with lysosomes, which contain a battery of degradative 14 
enzymes. In fact we were able to show that pH acidification renders mycobacteria more 15 
susceptible to kill with the highest susceptibility observed in BCG at a pH bellow 6.3 when 16 
compared to M. bovis (Jordao et al., 2008).  17 
Upon uptake of a pathogen by receptor-mediated phagocytosis into a macrophage, the 18 
resulting phagosome undergoes a series of fusion and fission events with the endocytic 19 
pathway. One of the important functional characteristics of the maturation process is that 20 
newly formed phagosomes, like early endosomes, mature to a state where they no longer 21 
fuse with early (or maturing) endosomes; only then can they fuse with late endosomes and 22 
lysosomes (Jahraus et al., 1998).  23 
Two theories of how the communication between the phagosome and the endosomal 24 
network and lysosomes occurs have been postulated – the kiss and run-hypothesis where 25 
the vesicles interact through transient fusion and fission events via a fusion-pore-like 26 
structure (Desjardins, 1995), and the fusion hypothesis where the phagosome completely 27 
fuses with pre-existing endosomes (Flannagan et al., 2009). It has been argued that the kiss 28 
and run-hypothesis is more probable since phagosomes do not acquire endosomal proteins 29 
and solutes simultaneously, and since molecules of different size are recruited from the 30 
same endosomal type at different time points (Tjelle et al., 2000). In addition to acquisition 31 
through interaction with endosomes and lysosomes, phagosomes can acquire proteins and 32 
lysosomal hydrolases from the trans Golgi network (Rohde et al., 2007).  33 
The ageing process of phagosomes is tightly regulated, although several pathogens have 34 
the capacity to subvert this process. During the late 1960s and early 1970s, D’Arcy Hart 35 
reported that pathogenic mycobacteria, including M. tuberculosis, are maintained in 36 
vacuoles that are not accessible to tracers known to be delivered to lysosomes, and that 37 
this ‘non-fusogenic’ phenotype correlates with the viability of the infecting organisms 38 
(Armstrong & Hart, 1975, Hart & Armstrong, 1974, Hart et al., 1972). These data marked 39 
one of the earliest applications of modern cell biological techniques to an intracellular 40 
bacterial infection. Indeed these seminal studies brought cell biology and microbiology 41 
together. 42 
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The demonstration that vacuoles containing M. tuberculosis contain both transferrin receptor 1 
and major histocompatibility complex (MHC) class II molecules indicates that they 2 
communicate with the cell plasma membrane (Clemens & Horwitz, 1995, Clemens & 3 
Horwitz, 1996). Although these vacuoles fail to fuse with lysosomes, they remain fusion-4 
competent, acquire some ‘lysosomal’ proteins from the synthetic pathway of the host cell, 5 
and undergo fusion with other vesicles of the early endosomal system. The consensus that 6 
has emerged in the literature is that pathogenic mycobacteria have evolved a strategy to 7 
arrest the normal maturation process of phagosomes after uptake by macrophages. Because 8 
of the paucity of the vesicular proton ATPase on the membrane of mycobacterial 9 
phagosomes, M. avium and M. tuberculosis phagosomes fail to acidify in the way that 10 
phagosomes with inert particles do (pH 4.5-5) and maintain a pH of around 6.3 (Sturgill-11 
Koszycki et al., 1994). In addition mycobacteria express a urease generating ammonia, which 12 
could buffer the lumen to counteract proton influx (Gordon et al., 1980). Moreover, 13 
mycobacterial phagosomes carry only limited amounts of lysosome-associated membrane 14 
proteins such as LAMP1, and have limited hydrolytic enzyme activity such as cathepsin 15 
B/L. Cathepsin D, which requires proteolytic and auto catalytic processing at low pH 16 
lysosomes to generate the enzymatically active form, is only present in its high molecular 17 
weight pro-form in mycobacterial phagosomes (Sturgill-Koszycki et al., 1996). This indicates 18 
that mycobacterial phagosomes are restricted from fusion events with downstream late 19 
endosomal/lysosomal compartments. 20 
Once an appreciation of the physiology of these vacuoles was attained, groups started to 21 
probe for proteins known to regulate the membrane fusion events associated with 22 
endosome–phagosome maturation. It is well established that small GTPases of the Rab 23 
family are present on certain organelles and take part in specific fusion events. For example, 24 
Rab5, which functions during early endosome homotypic fusion, is normally recruited to 25 
nascent phagosomes and dissociates from these vesicles as they acquire Rab7, another 26 
GTPase that functions during fusion of late endosomes and lysosomes. Rab5 is associated 27 
with, and retained by, phagosomes containing live Mycobacterium bovis (bacillus Calmette-28 
Guérin or BCG) or M. tuberculosis (Via et al., 1997). Rab5 is associated with phagosomes 29 
immediately after phagocytosis and facilitates the recruitment of Rab5 effector proteins, 30 
EEA1 and class III phosphatidylinositol-3-phosphate kinase which drives the synthesis of 31 
the early endosomal lipid phosphatidylinositol 3-phosphate (PI(3)P) (Vieira et al., 2001). 32 
PI3P interacts with Rab5 and EEA1 to promote endosome maturation. Membrane bound 33 
Rab5 is rapidly dissociated from the phagosome after its activation. Rab7 appears on the 34 
phagosome membrane after Rab5 dissociation and resides on the membrane during 35 
phagosome maturation (Vieira et al., 2003). After acquisition of Rab7, phagolysosome 36 
biogenesis is accelerated by the recruitment of Rab7-interacting-lysosomal-protein (RILP) to 37 
the phagosome (Harrison et al., 2003). Recently it was show that more Rab GTPases are 38 
recruited during progression of phagosome maturation and that their release and/or 39 
dissociation from M. tuberculosis-containing phagosomes has the relevance for the M. 40 
tuberculosis-induced inhibition of phagolysosome biogenesis. (Seto et al., 2011). Finally, the 41 
early endosomal v-SNARE cellubrevin is degraded on mycobacterial phagosomes, making it 42 
unavailable for fusion events and delivery of transport vesicles from the trans-Golgi (Fratti 43 
et al., 2002). 44 
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Rab GTPases also mediate a microtubule-based transport system that is likely to be 1 
responsible for providing the scaffold for endosome movement . Microtubules together with 2 
actin cytoskeleton are important for phagosome processing, for recycling from the 3 
phagosome and for phagosome intracellular transport and fusion with endocytic organelles 4 
(Southwick et al., 2003). In fact during maturation phagosomes move from the cell periphery 5 
to the perinuclear region where phagolysosome fusion occurs (Talaat et al., 2004). 6 
Manipulation of Rab and SNARE proteins is a key component of the survival strategy of 7 
Mycobacterium (Kumar et al., 2010). Moreover, expression of Rabs is down-regulated in 8 
patients with tuberculosis compared with healthy M. tuberculosis-infected donors (Jacobsen 9 
et al., 2005). We found that the synthesis of Rab34 was elevated in a NF-!B dependent 10 
manner in both M. smegmatis- and M. avium-infected macrophages. However, the regulation 11 
of this protein was the opposite in the two systems. In M. smegmatis-infected cells, NF- !B 12 
was a positive regulator, whereas in M. avium-infected cells it behaved as a negative 13 
regulator. Although the mechanism of this difference is open, these data suggest that M. 14 
avium has the ability to switch the transcriptional response linked to NF-!B to a state more 15 
conducive for its survival (Gutierrez et al., 2008). Rab34 has been shown to regulate 16 
lysosome positioning within the cell (Wang & Hong, 2002). Since lysosome positioning may 17 
be required for mycobacterial killing, we are testing the hypothesis that the regulation of 18 
Rab34 expression controls the ability of phagosomes to be positioned close to lysosomes.  19 
In addition to microtubules several studies have shown that actin filaments increase the 20 
uptake of ligands and their delivery to the degradative compartments downstream of the 21 
region where microtubules are required (Durrbach et al., 1996). The actin filaments also are 22 
involved in the motility and distribution of early endosomes via Rho D protein (Murphy et 23 
al., 1996). However, to what extent the actin filament network is required for interaction of 24 
phagosomes with early and/or late organelles of the endocytic pathway?  25 
It is clear that manipulation of actin’s fate by intracellular pathogens within the host 26 
cytoplasm is a key event that determines bacterial survival. The roles of actin in host-27 
microorganism interactions can be used to categorize pathogens into four groups: 1) some 28 
use actin to enter non phagocytic cells; 2) some use it to avoid uptake by phagocytic cells; 3) 29 
some use it to promote attachment to the host plasma membrane forming pedestals; 4) some 30 
escape from the phagosome and use the actin to move within cells and travel from cell to 31 
cell. In addition to the pathogens that have an extraphagosomal way of life, it is clear that 32 
some pathogens can modify the actin cytoskeleton from within the phagosome. 33 
Pioneer work by de Chastellier and co-workers indicates that intracellular Mycobacterium 34 
avium disrupt the macrophage actin filament network (Guerin & de Chastellier, 2000). 35 
Griffiths group showed that actin assembly by isolated latex beads phagosomes (LBP) 36 
correlates with their maturation status (Defacque et al., 2000). This in vitro assay monitors 37 
the polymerization of rhodamine-actin by phagosomal intact membranes in the presence of 38 
ATP and thymosin-#4 and in the absence of cytosolic extracts. The actin nucleation 39 
machinery, which includes the ezrin, radixin, moesin (ERM) protein family and 40 
phosphatidylinositol phosphates PIP and PIP2, are part of the membrane. Thymosin-#4 is 41 
used to prevent spontaneous actin nucleation at a concentration such that the phenomenon 42 
only occurs if a stimulator effector will induce the system. The standard assay works better 43 
at low ATP concentrations (0.2 mM) and the percentage of phagosomes that present red 44 
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actin dots in the LBP system is around 10-30% (Figure 1.A). At physiological concentrations 1 
of ATP (5mM) the system is blocked unless a stimulator will activate actin assembly 2 
(Defacque et al., 2000). Since LBP make cAMP at high ATP but not at low, via protein kinase 3 
A and cAMP is an inhibitor of actin assembly this may provide an explanation why the 4 
system is blocked at physiological concentrations of ATP (Kalamidas et al., 2006).  5 
Intriguingly in vitro, phagosomes containing live pathogenic Mycobacterium failed to induce 6 
actin assembly, whereas phagosomes containing avirulent or dead mycobacteria nucleated 7 
actin readily depending on the age (as for the latex beads system)(Anes et al., 2003) (Figure 8 
1.B).  9 
 10 
Fig. 1. Actin nucleation/assembly assay (red). (A) latex beads containing phagosomes. (B) 11 
Mycobacterium smegmatis-containing phagosomes 12 
We have accumulated a large set of correlative observations such that all conditions we have 13 
identified as being stimulating in the in vitro actin assembly assay also stimulated actin 14 
accumulation around phagosomes in vivo, phagosome fusion with late endosomes and 15 
lysosomes and the killing of mycobacteria, a consequence of phagolysosome fusion (Anes et 16 
al., 2003, Anes et al., 2006) (Figure 2). 17 
Conversely, compounds that inhibited in vitro actin assembly do not increase F-actin on 18 
phagosomes fail to promote phagolysosome fusion and favour growth of intracellular 19 
mycobacteria. Models have been developed to explain how actin filaments nucleated from 20 
the surface of a membrane organelle could “attract” other bound organelles toward it 21 
(Kjeken et al., 2004) (Figure3). Therefore we found conditions were phagosome maturation 22 
blockade by M. tuberculosis could be reversed to some extend by treating host infected cells 23 
with effectors that induced actin assembly and phagolysosome fusion with concomitant 24 
lumen acidification. 25 
 




Fig. 2. Actin assembly in vivo: conditions that increase actin in phagosomal membranes lead 2 
to increase membrane fusion with lysosomes, acidification and mycobacteria killing. Left 3 
panel: confocal microscopy; (red) F-actin rhodamin-phaloidin , (green) Mtb-GFP. Middle 4 
panel: EM of gold-containing lysosomes and fusion with phagosomes. Right panel, 5 
acidotrophic lysotracker red vesicles and phagosomes containing heat killed Mtb (green). 6 
 7 
Fig. 3. The actin track model. Actin filaments nucleated from the surface of a membrane 8 
organelle could “attract” other bound organelles toward it helping fusion events. Confocal 9 
microscopy showing aggregation of phagosomes with endosomes along actin filaments 10 
(red). 11 
4. Reversion of phagolysosome blockade by host effectors: Role of lipids, 12 
ATP, P2X7 receptor on actin assembly and on mycobacteria phagosome 13 
maturation 14 
Phagosome maturation is known to be influenced by the lipid species present on its 15 
membrane, although studies published have focused mostly on the kinase that generates 16 
phosphatidyl i n o s i tol-4-phosphate (PIP), and on PtdIns(4,5)P2 (PIP2), which binds actin 17 
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nucleation proteins (Vieira et al., 2002). The key role of PIP and PIP2 opened the door for the 1 
analysis of all lipids that interconnected with these phosphoinositides in the actin assembly 2 
process, as well as sphingolipids and fatty acids (Anes et al., 2003). 3 
The notion that M. tuberculosis may control phagosome maturation through the modulation 4 
of host lipids has been suggested by previous studies (Fratti et al., 2003), but the possible 5 
lipid mediators were not characterized. We showed that the enrichment of certain lipid, to 6 
mycobacteria-phagosome membranes stimulates the nucleation of actin and therefore 7 
phagosome maturation boosting the killing ability of macrophages to mycobacteria (Anes et 8 
al., 2003, Jordao et al., 2008). The F-Actin Stimulatory Factors (ASF) in the above 9 
experiments are the eicosanoide omega 6 arachadonic acid (AA), ceramide (Cer) and 10 
sphingosine-1-phosphate (S1P).  11 
An important role of ATP here is to be used by kinases to produce PIP, PIP2, S1P, ceramide-12 
1-phosphate (Cer1P) and phosphatidic acid (PA). All these phosphorylated lipids are 13 
stimulatory of F-actin at physiological concentrations of this purine. The incorporation of 14 
these phosphorylated lipids into the phagosomal membrane in the presence of ATP and 15 
ADP led to the translocation of ADP, but not ATP across the phagosomal membrane into the 16 
lumen. Once there, this ADP is converted to ATP by adenylate kinase activity. We propose 17 
that luminal ATP accumulates in response to selected lipids and activates the purinergic 18 
receptor P2X7R that signals across the phagosomal membrane to trigger actin assembly on 19 
the cytoplasmic membrane surface. (Kuehnel et al., 2009). P2X7R is a cationic channel, 20 
identified in the J774 macrophage latex bead phagosomes proteome (M. Desjardins, 21 
personal communication) that is able to bind via its cytoplasmic domain to a complex of 12 22 
proteins, including actin. Whereas LBP prepared from wild-type P2X7R- positive bone 23 
marrow macrophages could assemble actin and was stimulated by S1P or PIP at 24 
physiological concentrations of ATP, the equivalent LBP from P2X7R-knock-out mice 25 
macrophages failed to be stimulated by these lipids. This argues for a model in which PIP 26 
and S1P induce ATP accumulation in the phagosome lumen. This ATP then activates the 27 
P2X7R that signals downstream of the phagosome actin assembly machinery (Kuehnel et al., 28 
2009, Kuehnel et al., 2009b). From all these studies described above, its is now becoming 29 
clear that phagosomes are not passive vesicles that only acquire proteins and lipids via 30 
vesicular transport, or (for proteins) directly from the cytoplasm, and lose these components 31 
by recycling or dissociation. These organelles are also themselves capable of a plethora of 32 
biochemical activities, for example the enzymatic synthesis of different lipids. A dynamic 33 
description, including a predictive model of the interactions of lipids linked to PIP2 has 34 
recently been performed. This includes a systems level analysis of these lipids and other 35 
molecules on phagosomal membranes (Kuhnel et al., 2008). 36 
The inhibitors (AIF: for F-Actin inhibitor factors) include the eicosanoides omega 3 fatty 37 
acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Anes et al., 2003) and 38 
phosphatidylcholine (PC) (Treede et al., 2007). This group of lipids enriched in the 39 
membranes of infected cultures of macrophages protected the bacteria inducing the 40 
intracellular growth of M. tuberculosis and other mycobacteria. 41 
4.1 Eicosanoides, important immunoregulatory and host defence mechanisms in TB 42 
The omega 3 and omega 6 ratio are important for immunoregulatory and host defence 43 
functions. A striking effect on phagosomal-actin assembly, late fusion and killing of 44 
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mycobacteria was seen when a number of pro-inflammatory lipids, especially the omega-6 1 
fatty acid, arachidonic acid (AA), were added to J774 macrophages infected with the non-2 
pathogenic M. smegmatis or with virulent strains of M. tuberculosis. In contrast, the anti-3 
inflammatory omega-3 fatty acid eicosapentaenoic acid (EPA) induced an increase in 4 
mycobacterial growth in macrophages. These results were exciting because they fitted nicely 5 
into a general pattern seen with these groups of lipids in whole organisms. In support of 6 
this, three earlier studies showed that diets rich in omega-3 fatty acids led to significant 7 
increases in growth of Salmonella in mice (Chang et al., 1992) and M. tuberculosis in guinea 8 
pigs (Mayatepek et al., 1994, Paul et al., 1997). 9 
Indeed during the last years we have followed the effects of these lipids and their molecular 10 
effectors on the outcome of the infection in more complex systems than the macrophage cell 11 
culture model. Collectively, our data suggests that a high omega-6 fatty acids diet might be 12 
beneficial against mycobacteriosis, while a high omega-3 fatty acids diet might be 13 
detrimental. However, depending on the molecular effectors and, on the time during 14 
infection that the lipid is supplemented, opposite signaling effects were observed. The data 15 
with Koch’s bacilli raise an important public health question: are those individuals latently 16 
infected with M. tuberculosis, but asymptomatic at increased risk of reactivating the disease 17 
upon omega-3 fatty acids supplementation? 18 
Given this increasing tendency to advise and use omega-3 dietary supplements, which have 19 
beneficial effects among uninfected individuals it is important to evaluate their effect on 20 
patients suffering from tuberculosis and other infections since their impact on disease 21 
evolution is unknown. A literature search on the effects of omega-3 and -6 lipids on a variety 22 
of different pathogens, especially in animal models, the conclusion suggest that 23 
polyunsaturated fatty acids are not generally beneficial and are often detrimental. In a 24 
critical evaluation of all the experiments done to test the effects of omega-3 lipids in the 25 
context of infectious diseases Anderson and Fritsche concluded that there were “an equal 26 
number of papers published that report an adverse effect of omega-3 fatty acids on host 27 
infectious disease resistance as those that do not show an effect or show a beneficial 28 
effect”(Anderson & Fritsche, 2002). 29 
The results obtained by our group were surprising in that the opposite effects were seen in 30 
the animals, compared with observations in macrophages. For mycobacteria infected 31 
macrophages the omega-3 fatty acid, EPA, enhanced intracellular survival of M.tuberculosis 32 
while in infected mice an omega-3 fatty acid enriched diet promoted bacteria killing. When 33 
we looked at the effects of an omega-6 fatty acid enriched diet on the intracellular survival 34 
of intracellular pathogens we found no effect on M.tuberculosis infected mice while for 35 
salmonella infected animals the bacteria survival was improved (Jordao et al., 2008). From 36 
the perspective of actin assembly, our results were in agreement with the salmonella model 37 
because AA, by stimulating actin assembly will create an even higher actin meshwork 38 
around the salmonella containing vacuole preventing membranes contact and therefore 39 
fusion with lysosomes, thus protecting the bacteria. For the mycobacteria model the results, 40 
in infected macrophages, also agree with our model as AA, by increasing actin around 41 
M.tuberculosis phagosomes will help bacteria killing. In animals it may be the case that 42 
downstream breakdown products of the omega-6 fatty acid added to the diet could play 43 
opposite and more complex effects thus reflecting the lack of agreement regarding the 44 
outcome of the infection. 45 
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Eicosanoids are lipids responsible for many of the effects found in acute inflammation. 1 
Depending on the nature of the stimulus and the local pulmonary environment, the alveolar 2 
macrophage can be triggered to selectively release AA from membranes (Cochran et al., 3 
1987). Free AA thus becomes the substrate for the ciclooxygenase (COX) and 5-4 
lipoxygenases (5-LO) enzyme cascades that convert AA to a complex array of prostanoids, 5 
leukotrienes and lipoxins. The inflammatory response play a key role in shaping the 6 
adaptive response in large part through the secretion of an array of mediators such as 7 
interleukin 1# (IL-1#), IL-18, IL-12, tumor necrosis factor  " (TNF-"), prostaglandin E2 8 
(PGE2), leukotriene B4 (LTB4) and lipoxin A4 (LXA4) in response to the pathogen. EPA, 9 
another major source of eicosanoids present in membranes, inhibits these conversions and 10 
has a general anti-inflammatory role. However the enrichment of a membrane with EPA 11 
will transiently induce AA release that will become free for COX and 5-LO enzyme 12 
cascades. The long time enrichment of membranes with EPA will lead to AA depletion and 13 
to anti-inflammation by preventing AA conversion into the group of potent pro-14 
inflammatory modulators. Furthermore it will generate a class of PGs of the 3-series that are 15 
far less pro-inflammatory than those of the 2-series (Calder, 2002). 16 
Recently was found that the membrane of latex bead containing phagosome has the 17 
enzymes required to convert AA to a number of prostaglandins (PGs) (Griffiths G., personal 18 
communication). Moreover, some of these PGs, such as PGE2 inhibit actin assembly by LBP. 19 
In contrast, AA the precursor of PGE2, is a potent stimulator of phagosomal actin assembly. 20 
Here depending on whether there is accumulation of the precursor (AA) or the ending 21 
product (PGE2) opposite effects will be observed on the ability of phagosomal membranes 22 
to assemble actin. AA stimulating actin assembly will induce phagosome maturation and 23 
lysosomal pathogen killing while its product, with an inhibitory effect on actin assembly, 24 
will contribute to pathogen survival. 25 
5. Control through the transcription factor NF-!B on phagosome maturation 26 
and macrophage activation by signaling lipids 27 
A critical regulator of genes involved in inflammation is NF- !B (Caamano & Hunter, 2002). 28 
This transcription factor consists of two subfamilies: the ‘NF-!B’ proteins and the ‘Rel’ 29 
proteins which are present in the cytoplasm as hetero-dimers, in a complex with an 30 
inhibitor, I!B. When pro-inflammatory signaling occurs via activation of cell surface 31 
receptors such as the Toll-like receptors (TLR), I!B becomes phosphorylated. This releases 32 
the active subunits that enter the nucleus, where they up-regulate the transcription of 33 
hundreds of genes, a reflection of the complexity of this part of the inflammatory response 34 
(Natoli et al., 2005). In a recent study we showed that NF-!B is transiently activated early 35 
after infection of J774 cells and primary bone marrow derived macrophages with M. 36 
smegmatis. This activation is essential for mycobacterial killing since when NF-!B is blocked 37 
M. smegmatis survives. Using microarray analysis, we identified many lysosomal enzymes 38 
and membrane-trafficking regulators, including cathepsins, LAMP-2 and Rab34, were 39 
regulated by NF-!B during infection (Gutierrez et al., 2008). Our results argue that NF-!B 40 
activation increases the synthesis of membrane trafficking molecules, which may be rate 41 
limiting for regulating phagolysosome fusion during infection. The direct consequence of 42 
NF-!B inhibition is the impaired delivery of lysosomal enzymes to M. smegmatis 43 
phagosomes and reduced killing.  44 
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Whether or not pathogenic mycobacteria activate NF-!B is not clearly established, with 1 
different groups reporting conflicting results. Using confocal microscopy and ELISA, 2 
we observed a low and transient activation of NF-!B by M. avium. Similar results were 3 
reported before (Lee & Schorey, 2005). In contrast, others observed that high and low 4 
virulence strains of the M. avium-intracellular complex (MAC) activated NF-!B (Giri et al., 5 
1998). There are similar reports of NF-!B activation in macrophages infected with M. 6 
tuberculosis. However, many studies argue that the pathogens strongly block the 7 
proinflammatory response in general (Beltan et al., 2000). Based on our observations, we 8 
suggest the model in which pathogenic mycobacteria induce NF-!B activation upon 9 
contact with the macrophage. As soon as the mycobacteria start the synthesis and secretion 10 
of virulence effectors, the system may be repressed. A hitherto unappreciated benefit to the 11 
pathogen in inhibiting the NF-!B system is the consequence that the phagolysosome fusion 12 
events would also be blocked. In summary, our results pinpoint a novel role of the NF-13 
!B system to allow (directly or indirectly) the synthesis of molecules involved in 14 
intracellular trafficking. This regulation is linked to phagolysosome fusion, which facilitates 15 
killing of intracellular mycobacteria. In addition, our microarray screen identified a 16 
large number of potential new regulators of phagolysosome fusion; NF-!B is thus a key 17 
regulator of factors that facilitate the intracellular killing of mycobacteria. 18 
Many links have been described between lipids and NF-!B activation in different systems. 19 
For example, in Caco-2cells AA activates NF-!B whereas EPA had no effect (Ramakers et al., 20 
2007). Moreover, in the same cells phosphatidylcholine, which inhibits LBP actin assembly, 21 
inhibited NF-!B activation induced by TNF- " (Treede et al., 2007).  22 
In macrophages, sphingomyelin (SM), PIP and AA enhanced NF-!B activation and the cell 23 
surface expression of CD69, a macrophage activation marker regulated by NF-!B. Sph, S1P, 24 
EPA and PC failed to activate either NF-!B or CD69. Cer activated CD69 expression without 25 
activating NF-!B. In M. smegmatis-infected macrophages, SM, PIP and AA transiently 26 
activated NF-!B in a manner that was enhanced. In contrast Mycobacterium avium mostly 27 
repressed NF-!B activation and only SM and AA could induce its partial activation. While 28 
lipids that activate NF-!B in uninfected cells tend to kill mycobacteria in macrophages Sph 29 
and S1P failed to activate NF-!B under most conditions but nevertheless enhanced killing of 30 
M. smegmatis, M. avium and M. tuberculosis H37Rv. Our results argue that both NF-!B-31 
dependent and -independent mechanisms are involved in macrophage killing of 32 
mycobacteria and that both mechanisms can be enhanced by selected lipids (Gutierrez et al., 33 
2009). 34 
As stated above, NF-!B signaling could be also induced by TNF-". TNF-" signaling 35 
involves binding to members of TNF receptor super-family and recruitment of a complex of 36 
adapter proteins. Among these, TNF-receptor associated factors (TRAFs) activate several 37 
intracellular signal transduction pathways, in particular NF-!B and, Map kinases (MAPKs) 38 
that lead to modulation of gene expression by different transcription factors. Pathogenic 39 
mycobacteria tends to inhibit all these pathways (Gutierrez et al., 2008, Schorey & Cooper, 40 
2003).  41 
MAPKs are central players in cell signaling and much of their activities are localized on 42 
membranes. There are three different classes of these kinases, namely ERK, JNK and p38. A 43 
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number of studies have shown that these kinases are activated upon infection with 1 
mycobacteria (Schorey & Cooper, 2003). Moreover, p38 and ERK are activated more during 2 
infection with non-pathogenic compared with pathogenic mycobacteria, implying that the 3 
pathogens inhibit these kinases (Roach & Schorey, 2002). The kinase p38 has been implicated 4 
in early endosome fusion; Fratti and colleagues also associated p38 activation with an 5 
inhibition of phagosome maturation in cells infected with Mycobacterium bovis (BCG) (Fratti 6 
et al., 2003). We additionally provided evidence for its importance in regulating phagosomal 7 
actin assembly (Anes et al., 2006). By inhibiting this kinase, a block on phagosome actin 8 
assembly in vitro was observed. In vivo p38 inhibition, blocked phagosome maturation and, 9 
increased survival of M. smegmatis within J774 macrophages. We also found that in 10 
M.tuberculosis-infected macrophages TNF-" secretion was stimulated by treatment with AA, 11 
whereas EPA inhibited this process (Jordao et al., 2008b). In line with this, AA strongly 12 
activated the pro-inflammatory MAPK p38 in uninfected cells but M.tuberculosis infected 13 
cells blocked the ability of AA to activate p38 leading us to conclude that AA-dependent 14 
killing is therefore independent of p38. 15 
6. Control through programmed cell death and inflammation: Inflammasome 16 
activation by Koch’s bacilli 17 
Several intracellular pathogens, including Leishmania, Coxiella, Salmonella, Chlamydia and 18 
Yersinia, induce host-cell apoptosis as a way of minimizing the inflammatory response and 19 
avoid detection (Bergsbaken & Cookson, 2007, John & Hunter, 2008, Peters et al., 2008). In 20 
some of these cases, the induction of host-cell necrosis, sometimes by pyroptosis, leads to 21 
lower bacterial viability and is beneficial to the host (Haimovich & Venkatesan, 2006). Other 22 
acute bacterial pathogens, such as Pseudomonas, Neisseria and Streptococcus, are cleared 23 
by host-cell apoptosis, and these pathogens evade innate immunity by inhibiting apoptosis 24 
(Tunbridge et al., 2006). Virulent strains of M. tuberculosis induce necrosis of both human 25 
and mouse macrophages, whereas attenuated M. tuberculosis strains or other nonpathogenic 26 
mycobacterial species generally do not (Divangahi et al., 2009). In addition, there is 27 
accumulating evidence that apoptosis, whether induced by the pathogen itself, 28 
pharmacologically or by cytotoxic lymphocytes results in lower viability of M. tuberculosis 29 
(Duan et al., 2001, Gan et al., 2008, Oddo et al., 1998). 30 
One strategy used by M. tuberculosis to avoid apoptosis is the subversion of host eicosanoid 31 
biosynthetic pathways. The finding that M. tuberculosis infection significantly increases the 32 
membrane release of AA via activation of cPLA2 $ (Duan et al., 2001) and that mice knock-33 
out for 5-LO are more resistant to M. tuberculosis infection (Bafica et al., 2005) raised the 34 
question of whether eicosanoid production is involved in macrophage necrotic programme 35 
cell death and inhibition of apoptosis induced by virulent M. tuberculosis. The attenuated M. 36 
tuberculosis strain H37Ra induces the production of prostaglandin E2 (PGE2), which protects 37 
the mitochondrial inner membrane and induces the repair of plasma membrane 38 
microdisruptions inflicted by the pathogen (Keane et al., 2000). These events protect the host 39 
macrophages against necrosis and instead promote apoptosis. In contrast, intra-cellular 40 
infection with the virulent H37Rv strain of M. tuberculosis induces the production of lipoxin 41 
A4 (LXA4), which inhibits cyclooxygenase production and PGE2 biosynthesis. In a 42 
PGE2-poor microenvironment, macrophages cannot prevent the mitochondrial damage or 43 
repair the plasma membrane disruptions caused by M. tuberculosis, and this leads to 44 
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necrosis. Virulent M. tuberculosis in pre-necrotic macrophages continues to replicate and to 1 
spread to uninfected macrophages after the cells are lysed. Thus, the balance of PGE2 and 2 
LXA4 regulates the relative amounts of apoptosis and necrosis after M. tuberculosis infection, 3 
with important functional consequences for innate control of the intracellular infection.  4 
Pyroptosis in the context of tuberculosis is controversial: from one side it leads to potent 5 
pro-inflammation that drives the active disease; from other side allows the release of 6 
intracellular bacteria and their escape to hydrolytic digestion. At one point in the life of an 7 
intracellular Koch’s bacillus, there comes the time to exit the cell and infect the next one. In 8 
the larger scale of the human infection, mycobacteria need to access a novel host organism. 9 
In the infectious stage bacilli are coughed up and aerosolized within microdroplets. 10 
Dissemination of the infection therefore requires leaking of bacilli out of caseating necrotic 11 
foci or caverns into the alveolar space, which is promoted by exacerbated inflammation and 12 
massive cell death. Intranasal lipopolysaccharide treatment simultaneously to M. tuberculosis 13 
infection in mice induced necrotic lesions, otherwise not seen in this animal model for TB, 14 
indicating the importance of inflammatory stimuli for caseating necrosis. 15 
This necrotic programme of cell death results from the assembly of inflammasomes, a 16 
complex of pattern recognition cytosolic receptors (NLRs: NOD-like receptors) (reviewed by 17 
(Sirard et al., 2007)) and adaptor proteins containing caspase recruitment domains (CARD) 18 
which are able to recruit and activate pro-caspase-1. Mature Casp-1 then activates the 19 
isoforms of pro-IL-1# and pro-IL-18 and the active pro-inflammatory interleukins are then 20 
secreted through exosomes, concomitant or not with induction of pyroptosis. In humans, the 21 
NLR family has at least 20 members. Structuraly, NLRs are characterized by their 22 
nucleotide-binding oligomerization domain (NOD), a leucin-rich domain that recognizes 23 
pathogen associated molecular patterns (PAMPs) and a signalling domain that either 24 
triggers NF- !B, or other signaling platforms such as MAPK, type 1 interferon pathways or 25 
induces inflammasome activation. 26 
Different NLRs associate with each other and CARD-containing protein adaptors to form 27 
diverse inflammasome complexes in response to different bacterial elicitor molecules or 28 
endogenous danger signals. For example, the Salmonella and Legionella flagellin proteins are 29 
sensed by an NLRC4/CARD12/CLAN inflammasome (Mariathasan et al., 2004) whereas 30 
muramyl dipeptide (MDP) is sensed by NLRP1 and NLRP3 inflammasomes (Martinon et al., 31 
2004). Various microbial toxins have also been shown to activate the inflammasome (Nour et 32 
al., 2009). The NLRP3/CIAS1/Cryopyrin inflammasome is activated either by uric acid 33 
crystals formed during gout, silica, asbestos or cathepsin B as well extracellular ATP 34 
released from necrotic cells (Cassel et al., 2008, Mariathasan et al., 2006). 35 
M. tuberculosis resides largely within a phagosome-like compartment of host macrophages 36 
during infection (Jordao et al., 2008). Inflammasome activation it is postulated to occur only 37 
if these effectors or products from a signalling cascade reach the cytosol and gain access to 38 
NLRs. Despite its apparent sequestration from the cytosol, M. tuberculosis has been shown to 39 
trigger NLR pathways that induce type I IFN expression. This recognition event depends on 40 
the ESX-1 specialized protein secretion system of the bacterium (Pandey et al., 2009). ESX-1 41 
has been shown to be involved in the perturbation of host cell membranes, and has therefore 42 
been hypothesized to promote type I IFN production by facilitating the delivery of bacterial 43 
products into the cytosol including those responsible for secretion of the virulence-44 
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associated antigens ESAT-6 and the CFP-10 (Stanley et al., 2007). Indeed this is in agreement 1 
with recent findings that support the escape of M. tuberculosis from the phagosome to the 2 
cytosol at latter times post-infection in human primary macrophages and DCs (van der Wel 3 
et al., 2007). Some groups claimed that M. tuberculosis blocks inflammasome activation 4 
(Master et al., 2008). However part of the experiments were performed using BCG and 5 
because this attenuated strain had lost the complete RD1 region that codifies for ESX-1 and 6 
ESAT6 is unable to secrete important PAMPs to the cytosol that may be envolved in 7 
inflammasome activation. The same logic is applied for the use of the attenuated M. 8 
tuberculosis H37Ra, which has a mutation in PhoP which inhibits ESX-1 function, pre-9 
dominantly prevents necrosis and leads to sequestration and decimation of the intracellular 10 
bacteria (Chen et al., 2006). It has previously been shown that the secreted mycobacterial 11 
protein ESAT-6 in its purified form induces cell death in macrophages (Derrick & Morris, 12 
2007) and that the protein has membrane-lysing activity (Smith et al., 2008). This makes 13 
ESAT-6 an attractive candidate as the bacterial factor responsible for necrosis. Lerm group 14 
found that deletion of the gene encoding ESAT-6 or of the RD1 region led to abrogation of 15 
the necrosis-inducing effect of M. tuberculosis as well as diminished IL-1# secretion by the 16 
host macrophage (Welin et al., 2011). 17 
Recent studies have demonstrated that casp-1 activation and subsequent IL-1# synthesis are 18 
strongly upregulated in M. tuberculosis-infected macrophages (Montero et al., 2004), and 19 
inflammasome activation occurs upon M. tuberculosis infection (Netea et al., 2006). Finally, 20 
M. tuberculosis infection was proved to be sensed by NOD2, a cytosolic NLR that recognizes 21 
a component of peptidoglycan found in mycobacterial cell wall (Ferwerda et al., 2005). 22 
Another mycobacterial protein, a metalloprotease was so far the unique demonstrated to 23 
suppress the IPAF/NLRC4 inflammasome (Master et al., 2008). 24 
Our group hypothesized that inflammasome activation is triggered by M. tuberculosis 25 
components that cross the phagosomal barrier where they are sensed by cytosolic pattern 26 
recognition receptors (PRRs) to activate the inflammasome and thereby promote IL-1# 27 
maturation. It was demonstrated that casp-1 activation depends on live intracellular bacteria 28 
that express a functional ESX-1 system. The contribution of ESX-1 appears to be attributable 29 
to the ESAT-6 protein, which facilitates the diffusion of other bacterial products such as 30 
AG85 into the cytosol. Casp-1 activation was found to be increased after co-challenge of 31 
individual M. tuberculosis PAMPs such as AG85, PIM1/2, mAGP, Man-LAM and PGN 32 
(Mishra et al., 2010).  33 
To identify the components of the inflammasome most important during M. tuberculosis 34 
infection, a shRNA-based screen was carried out to silence individual NLR and CARD 35 
proteins selectively in THP-1 monocytes. These cells were transduced with a panel of 36 
lentivirus-encoding shRNAs that targeted 22 NLRs and 14 CARD domain-containing 37 
proteins in the human genome. We further identify an NLRP3 and ASC-containing complex 38 
as the major inflammasome activated in macrophages by M. tuberculosis infection, and 39 
implicate a number of other NLR and CARD proteins in this process. Nine genes were 40 
considered to be either positive or negative regulators of inflammasome function during M. 41 
tuberculosis infection, six genes played a role upon ESAT-6 stimulation, and 14 genes were 42 
important upon dual stimulation with ESAT-6 and AG85. Most of the shRNAs that inhibited 43 
IL-1# secretion in ESAT-6 pulsed cells also inhibited this response when ESAT-6 was added 44 
together with AG85. Most importantly, knock-down of NLRP3/CIAS1, PYCARD/ASC and 45 
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CARD6 resulted in a similar inhibition of IL-1# secretion in all the three conditions tested 1 
(Mishra et al., 2010). 2 
In addition to NLRP3 and ASC, we found that depletion of CARD6 also impaired IL-1# 3 
secretion in response to all stimuli. CARD6 has been shown to positively regulate NF-kB 4 
activation (Dufner & Mak, 2006). Although CARD6 was important for IL-1# secretion in 5 
response to both live bacteria and isolated components, we were not able to detect a 6 
physical interaction between CARD6 and the other inflammasome components including 7 
casp-1. Thus, we speculate that CARD6 may not be involved directly in inflammasome 8 
assembly during M. tuberculosis infection, but may promote IL-1# production by regulating 9 
the synthesis of proIL-1# by activating NF-kB family of transcription factors. Consistent 10 
with the previously published reports, we identified NOD2 as one of the sensors for M. 11 
tuberculosis infection.  12 
IL-1# secretion was also impaired upon depletion of CARD12/NLRC4 when cells were 13 
challenged with ESAT-6 plus AG85, which might suggest the involvement of more than one 14 
inflammasome platform in the regulation of IL-1# release during M. tuberculosis infection. 15 
The mycobacterial cord factor Trehalose-6, 6-dimycolate (TDM; also called cord factor) is a 16 
mycobacterial cell wall glycolipid that may be the most studied immunostimulatory 17 
component of M. tuberculosis. Macrophages detect TDM through a recently identified C-type 18 
lectin receptor-‘Mincle’ and produce inflammatory cytokines (Ishikawa et al., 2009). This 19 
activation most likely proceeds through a Syk-CARD9-Bcl10-Malt1 signalling pathway to 20 
induce a specific innate activation programme that is distinct from the response to TLR 21 
ligands (Werninghaus et al., 2009).  22 
 23 
Fig. 4. NLR’s and CARD-containing protein adaptors that responds to Koch’s infection and 24 
to major PAMPs ESAT-6 and ESAT-6 co-challenged with AG85. 25 
Recent reports have identified CARD9 as a central integrator of various PRR signaling 26 
pathways (Colonna, 2007). We observed that a component of the IL-1# secretion in 27 
macrophages challenged with ESAT-6 and with ESAT-6 plus AG85 depended on CARD9. 28 
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Together these data support an important role for CARD9 in the innate immune response 1 
triggered by M. tuberculosis infection, ESAT-6, AG85 and TDM. In conclusion our data 2 
suggest a previously unrecognized role for ESAT-6 in aiding the access of mycobacterial 3 
PAMPs such as AG85 to the macrophage cytosol eliciting casp-1 activation and IL-1# 4 
secretion. The observation that IL-1# and NLRP3 mRNA is induced in macrophages derived 5 
from patients with active TB indicates that a similar inflammatory pathway is likely to be 6 
important for the pathogenesis of human TB (Mishra et al., 2010). 7 
Targeting cytosolic receptors or their adapters and therefore blocking the most relevant 8 
inflammasomes to be assembled during latent infection may prevent the active disease by 9 
decreasing pro-inflammatory responses that drives intracellular bacteria release from 10 
macrophages and the necrosis of the granuloma.  11 
7. Conclusion  12 
From the above review of the literature, it is evident that the interaction between the Koch’s 13 
bacillus and the host macrophage is essential in determining the outcome of infection. 14 
However, the way in which the bacteria subvert the response of the macrophage originally 15 
designed to kill is still not completely understood. There are gaps in the knowledge, 16 
including how the bacteria inhibit phagosomal maturation and how the bacilli induce cell 17 
death. Furthermore, although a lot of effort has gone into studying phagosomal maturation 18 
in the context of M. tuberculosis, it is still not clear what determines the outcome of infection. 19 
The deciding factors for overcoming the block in phagosomal maturation, the crucial 20 
determinants in controlling the bacilli and disabling their replication, and the activation 21 
factors necessary to enhance macrophage function to remove the infection are not fully 22 
known. The dogma that inhibition of phagolysosomal fusion is the determinant factor that 23 
allows mycobacterial growth has not been well substantiated in a human system. 24 
Furthermore, methods designed to study these factors are needed to enable a better 25 
understanding. Many pieces of information come from studies of mouse or other animal 26 
models, and are based on results obtained with avirulent species of mycobacteria and the 27 
extrapolation of these to the human in vivo situation is often difficult. 28 
The most pressing questions that emerge from the current body of data on M. tuberculosis 29 
fall into two discrete categories. First, how does the bacterium modulate the endocytic 30 
network of its host cell? Although the answer to this question is important for our 31 
understanding of the bacterium’s success as a pathogen, it is unlikely to give rise to a 32 
treatment for infection because reversal of this phenotype would probably be difficult to 33 
achieve locally, and systemic modulation of endosome–lysosome fusion does not strike me 34 
as a feasible solution. Second, how can our appreciation of the environment in which the 35 
bacterium finds itself be exploited to result in new or improved ways to fight infection? 36 
Understanding the position of the vacuole within the endosomal continuum could lead to 37 
improved drug delivery. Most important, however, is the need to increase our knowledge of 38 
the intralumenal environment within the vacuole. If we want to screen for, and isolate, new 39 
drugs against relevant targets, we have to develop a more detailed understanding of the 40 
environment within the lumen of the endosomal vesicles. A huge amount of activity has 41 
been devoted to membrane fusion and its modulation by cytosolic mediators. A much 42 
greater understanding of the content of the endosomal–lysosomal milieu is needed. What 43 
are the concentrations of metal ions? What is the form and abundance of lipids and fatty 44 
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acids? These questions are key to our appreciation of both intracellular infection and to our 1 
understanding of the physiology of the endosomal system. 2 
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